From: Burden, clinical presentation and risk factors of advanced HIV disease in pregnant Mozambican women
Variable | Unadjusted | Adjusted | ||||||
---|---|---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95% CI | P-value | |||
Age group (years) | < 20 | 1 | 0.012 | 1 | 0.018 | |||
20–24 | 2.24 | 1.16; 4.34 | 2.27 | 1.17; 4.40 | ||||
25–34 | 1.31 | 0.7; 2.48 | 1.34 | 0.71; 2.55 | ||||
> 35 | 1.59 | 0.77; 3.30 | 1.56 | 0.74; 3.28 | ||||
Gestational age at first ANC visit | 1.00 | 0.97; 1.03 | 0.957 | 1.17 | 0.8; 1.71 | 0.954 | ||
WHO Clinical Stage | I | 1 | < 0.001 | 1 | 0.002 | |||
II | 0.66 | 0.31; 1.40 | 0.73 | 0.34; 1.56 | ||||
III | 0.80 | 0.36; 1.79 | 0.87 | 0.39; 1.98 | ||||
IV | 8.33 | 2.61; 26.56 | 9.59 | 2.94; 31.27 | ||||
CD4 count (cells/mm3) | < 200 | 1 | 0.056 | 1 | 0.045 | |||
≥ 200 | 1.73 | 0.89; 3.83 | 1.92 | 0.97; 3.83 | ||||
ART start | Before first ANC visit | 1 | 0.606 | 1 | 0.417 | |||
After first ANC visit | 1.13 | 0.78; 1.62 | 1.34 | 0.79; 2.27 |